Correlation of BRCA1/2 mutations with response to immune checkpoint inhibitors in colorectal cancer.

被引：0
|
作者：
Jia, Dong-Dong [1 ]
Niu, Yanling [2 ]
Ma, Tonghui [2 ]
Shi, Min [2 ]
机构：
[1] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China
[2] Genetron Hlth Beijing Technol Co Ltd, Beijing, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1681
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors
    Zhou, Zhijun
    Li, Min
    JAMA NETWORK OPEN, 2021, 4 (05)
  • [2] BRCA1 and BRCA2 founder mutations are not associated with a high risk of colorectal cancer.
    Niell, BL
    Rennert, G
    Tomsho, LP
    Bonner, JD
    Gruber, SB
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 253 - 253
  • [3] BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer - Response
    Rennert, G
    Bonner, JD
    Gruber, SB
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15): : 1185 - 1186
  • [4] BRCA1 and BRCA2 mutations and the risk for colorectal cancer
    Sopik, V.
    Phelan, C.
    Cybulski, C.
    Narod, S. A.
    CLINICAL GENETICS, 2015, 87 (05) : 411 - 418
  • [5] BRCA1/2 germline mutations and response to PARP inhibitor treatment in lung cancer.
    Fang, Wenfeng
    Cai, Xiuyu
    Zhou, Huaqiang
    Wang, Yinguang
    Zhang, Yaxiong
    Hong, Shaodong
    Shao, Yang
    Zhang, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] BRCA1 mutations and colorectal cancer in Poland
    Janina Suchy
    Cezary Cybulski
    Bohdan Górski
    Tomasz Huzarski
    Tomasz Byrski
    Tadeusz Dębniak
    Jacek Gronwald
    Anna Jakubowska
    Dominika Wokołorczyk
    Grzegorz Kurzawski
    Józef Kładny
    Arkadiusz Jawień
    Zbigniew Banaszkiewicz
    Rafał Wiśniowski
    Piotr Wandzel
    Jacek Starzewski
    Zbigniew Lorenc
    Elżbieta Korobowicz
    Piotr Krokowicz
    Karolina Horbacka
    Jan Lubiński
    Steven A. Narod
    Familial Cancer, 2010, 9 : 541 - 544
  • [7] BRCA1 mutations and colorectal cancer in Poland
    Suchy, Janina
    Cybulski, Cezary
    Gorski, Bohdan
    Huzarski, Tomasz
    Byrski, Tomasz
    Debniak, Tadeusz
    Gronwald, Jacek
    Jakubowska, Anna
    Wokolorczyk, Dominika
    Kurzawski, Grzegorz
    Kladny, Jozef
    Jawien, Arkadiusz
    Banaszkiewicz, Zbigniew
    Wisniowski, Rafal
    Wandzel, Piotr
    Starzewski, Jacek
    Lorenc, Zbigniew
    Korobowicz, Elzbieta
    Krokowicz, Piotr
    Horbacka, Karolina
    Lubinski, Jan
    Narod, Steven A.
    FAMILIAL CANCER, 2010, 9 (04) : 541 - 544
  • [8] BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer
    Friedenson, B
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15): : 1184 - 1185
  • [9] BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer
    Niell, BL
    Rennert, G
    Bonner, JD
    Almog, R
    Tomsho, LP
    Gruber, SB
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (01): : 15 - 21
  • [10] The prevalence of BRCA1 and BRCA2 mutations in Chinese women with breast cancer.
    Hu, Z.
    Li, W-F
    Song, C-G
    Shen, Z-Z
    Huang, W.
    Shao, Z-M
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S250 - S250
12345